Abruptio Placentae
8
1
1
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
25.0%
2 terminated out of 8 trials
60.0%
-26.6% vs benchmark
13%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (8)
Enhancing Prediction of Adverse Pregnancy Outcomes in Africa Through Partnerships and Innovation
Plasma Concentration of Biological Markers in Placental Abruption
Spanish Registry of Pregnant Women With COVID-19
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
The Use of Fetal Fibronectin to Predict Delivery Due to Abruptio Placenta
Magnesium Sulfate vs Placebo for Placental Abruption
Progesterone for First Trimester Vaginal Bleeding
Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome